Search results
Results from the WOW.Com Content Network
For the period ending Aug. 31, its sales grew by 13% year over year to $200 million. But of that total, less than one-third (31%) of sales actually came from its cannabis operations.
Is there a catalyst out there that can help Tilray's stock rebound in 2025? The last time Tilray's stock finished a year in positive territory was back in 2018, when its shares jumped by more than ...
Industry analysts forecast the market could reach $444 billion by 2030, representing a compound annual growth rate (CAGR) of 34.03% from 2023. ... Tilray has seen its stock price plummet a ...
In its fiscal first quarter of this year, ended Aug. 31, 28% of its total revenue, or $55.9 million, was from alcohol sales, whereas 31%, or $61.2 million, was from cannabis.
It's hard to believe, but the 52-week high for Tilray (NASDAQ:TLRY) is $300. TLRY reached its nose-bleed valuation last October. Except for a couple of rallies, it's been downhill ever since ...
Tilray's stock continues moving in the wrong direction, and its share price is less than $2. Even at these levels, I'd recommend that investors stay away. Don’t miss this second chance at a ...
Less than a year ago, Tilray (NASDAQ:TLRY) traded at an eye-popping $300 a share. But Sept. 19 is a long time ago in the cannabis investing world, as TLRY stock fell steadily since that time ...
In the budding cannabis industry, there will be winners and losers. And for one-time heavyweight contender Tilray (NASDAQ:TLRY), a mixed earnings report has delivered another blow. But don't think ...